Cite Filings / DNLI / 0001921094-23-000497
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Denali Therapeutics Inc. · Filed 2023-08-15 · Acc 0001921094-23-000497

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2023-08-21 144 Sale of Securities
  • 2023-08-15 144 Sale of Securities
  • 2023-08-14 144 Sale of Securities
  • 2023-08-14 144 Sale of Securities
  • 2023-08-14 4 President and CEO sold 2,526 shares at $25.03 ($63,226)
  • 2023-08-14 4 Chief Medical Officer sold 2,857 shares at $24.15 ($68,997)
  • 2023-08-14 4 COFO and Secretary sold 2,853 shares at $24.18 ($68,986)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…